0 Reacties
0 aandelen
360 Views
0 voorbeeld
Zoeken
Ontdek nieuwe mensen, nieuwe verbindingen te maken en nieuwe vrienden maken
-
Please log in to like, share and comment!
-
Ultomiris Drug Market: Growth, Trends, and Global ForecastMarket Overview The global Ultomiris drug market is experiencing strong growth, driven by increasing adoption of advanced biologic therapies for rare diseases. The market is projected to grow from USD 5.2 billion in 2025 to USD 14.9 billion by 2033, registering a CAGR of 14.4%. Ultomiris (ravulizumab), developed by Alexion Pharmaceuticals, is a long-acting C5 complement...0 Reacties 0 aandelen 243 Views 0 voorbeeld
-
Ultomiris Market Trends, Growth Drivers, and Future Outlook (2026–2033)Ultomiris Drug (ravulizumab) Market is a long-acting monoclonal antibody developed to treat rare complement-mediated disorders. As a C5 complement inhibitor, it plays a critical role in managing diseases such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder...0 Reacties 0 aandelen 32 Views 0 voorbeeld